Exchange: NASDAQ·Updated 09:56 AM EDT

PPBTPurple Biotech Ltd - ADR

$1.42
$0.05
(3.65%)
Today
Mkt Cap$2.22M
Vol7,582.00
News
all
press releases
Purple Biotech CEO Gil Efron To Step Down For Health Reasons
(RTTNews) - Purple Biotech Ltd. (PPBT), a clinical-stage pharmaceutical company, Friday announced that its Chief Executive Officer, Gil Efron will step down from his role in August, due to health...
Nasdaq News: Markets
More News
Purple Biotech Shares Soar 92% On Breakthrough For Experimental Cancer Drug
Stocktwits
Purple Biotech's Shrinking Losses Keep Retail Sentiment In The Green, But Other Pressures Loom
As of Dec. 31, 2024, Purple Biotech had $8.2 million in cash and short-term deposits, which it expects will be sufficient to fund operations into mid-2026.
Stocktwits
News Movers: Yesterday’s Hottest News That Could Move the Needle Today
Your Only Digest of Market-Moving News and Rumours From High-Growth, Small Cap Stocks
Stocktwits Contributor
Purple Biotech Stock Hits Nearly 2-Month High On Cancer Drug Trial Success: Retail Thrilled
CM24 targets CEACAM1, a multi-functional membrane glycoprotein that plays a critical role in tumor invasiveness, metastasis, and immune evasion.
Stocktwits
<
1
>

Advertisement|Remove ads.